[1]CurrentPatentAssignee:ELILILLY&CO-US2016/176896,2016,A1
[2]CurrentPatentAssignee:ELILILLY&CO-US2016/176896,2016,A1
[3]CurrentPatentAssignee:ELILILLY&CO-WO2018/5234,2018,A1
[4]CurrentPatentAssignee:ELILILLY&CO-WO2018/5234,2018,A1
[5]CurrentPatentAssignee:ELILILLY&CO-WO2018/5234,2018,A1
[1]CurrentPatentAssignee:ELILILLY&CO-US2016/176896,2016,A1
[2]CurrentPatentAssignee:ELILILLY&CO-US2016/176896,2016,A1
[3]CurrentPatentAssignee:ELILILLY&CO-WO2018/5234,2018,A1
[4]CurrentPatentAssignee:ELILILLY&CO-WO2018/5234,2018,A1
[5]CurrentPatentAssignee:ELILILLY&CO-WO2018/5234,2018,A1
[1]CurrentPatentAssignee:ELILILLY&CO-US2016/176896,2016,A1
[2]CurrentPatentAssignee:ELILILLY&CO-US2016/176896,2016,A1
[3]CurrentPatentAssignee:ELILILLY&CO-WO2018/5234,2018,A1
[4]CurrentPatentAssignee:ELILILLY&CO-WO2018/5234,2018,A1
[5]CurrentPatentAssignee:ELILILLY&CO-WO2018/5234,2018,A1
[1]CurrentPatentAssignee:ELILILLY&CO-US2016/176896,2016,A1
[2]CurrentPatentAssignee:ELILILLY&CO-US2016/176896,2016,A1
[3]CurrentPatentAssignee:ELILILLY&CO-WO2018/5234,2018,A1
[4]CurrentPatentAssignee:ELILILLY&CO-WO2018/5234,2018,A1
[5]CurrentPatentAssignee:ELILILLY&CO-WO2018/5234,2018,A1
[1]CurrentPatentAssignee:ELILILLY&CO-US2016/176896,2016,A1
[2]CurrentPatentAssignee:ELILILLY&CO-WO2018/5234,2018,A1
[3]CurrentPatentAssignee:ELILILLY&CO-WO2018/5234,2018,A1
Title: Shripad V. Bhagwat, et al. Abstract 4973: Discovery of LY3214996, a selective and novel ERK1/2 inhibitor with potent antitumor activities in cancer models with MAPK pathway alterations. Cancer Research. July 2017.